<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz
UCB is snapping up U.S. autoimmune biotech Candid Therapeutics for $2.2 billion

The Belgian pharma company is paying $2 billion upfront for Candid's pipeline of T-cell engagers targeting autoimmune diseases [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

thenextweb
UCB pays up to $2.2bn for Candid Therapeutics, doubling down on T-cell engagers in autoimmune disease

The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseas [...]

Match Score: 188.75

thenextweb
Cambridge biotech STORM Therapeutics raises $56M

STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by e [...]

Match Score: 63.00

Destination
Viking Therapeutics closer to bringing its Ozempic competitor to market

Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year partnership with CordenPharma, a leading contract manufacturing firm.Read more... [...]

Match Score: 36.94

venturebeat
Anthropic says it hit a $30 billion revenue run rate after 'crazy' 80x growth

Dario Amodei is not the kind of CEO who talks loosely about numbers. The Anthropic co-founder and chief executive, a former VP of research at OpenAI with a PhD in computational neuroscience from Princ [...]

Match Score: 36.57

thenextweb
Danish biotech Cellugy wants to replace microplastics in cosmetics

Danish biotech Cellugy has raised €8.1mn in EU funding to accelerate production of a biodegradable material designed to replace microplastics in cosmetics. The grant, awarded under the EU’s LIFE P [...]

Match Score: 33.65

thenextweb
NATO’s VC fund backs biotech startup for first time

The NATO Innovation Fund (NIF) has made its first investment in a biotechnology startup. The alliance’s VC arm announced today that it’s co-leading a $35mn Series A round for UK-based Portal Biote [...]

Match Score: 33.65

venturebeat
Microsoft and OpenAI gut their exclusive deal, freeing OpenAI to sell on AWS and Google Cloud

Microsoft and OpenAI on Monday announced a sweeping overhaul of the partnership that has defined the commercial AI era, dismantling key pillars of exclusivity and revenue-sharing that bound the two co [...]

Match Score: 33.46

qz
Eli Lilly is buying cancer biotech Kelonia Therapeutics for more than $2 billion

The deal expands Lilly's in vivo CAR-T cancer therapy pipeline, anchored by a multiple myeloma drug that showed early clinical results [...]

Match Score: 28.29

qz
Seaport Therapeutics stock pops 17% on Nasdaq debut after raising $255 million in upsized IPO

The Boston-based biotech sold more stock than originally planned at $18 a share, giving it a market value of $1.1 billion [...]

Match Score: 28.29